close
"D"efend Osteoporosis: The Myth and Truth about Vitamin D
New Perspectives on T2MD Pathophysiology and a Novel Treatment Option - DPP-4 Inhibition: Sitagliptin
The Rationales of Using ARB in Patients with Diabetic Nephropathy
Aggressive Cholesterol Management Benefit for T2MD Patients
The Grand Formosa Regent, Taipei
2008 06 01 09:30~14:00
全站熱搜
留言列表
心情 (5)